Cyclooxygenase-2 Inhibitor Inhibits the Fracture Healing.
Authors:
- Koichi SairyoKSKoichi Sairyo
- Shinji KomatsubaraSKShinji Komatsubara
- Takahiro SasaTSTakahiro Sasa
- Hiroshi EgawaHEHiroshi Egawa
- Daisuke YonekuraDYDaisuke Yonekura
- Keisuke AdachiKAKeisuke Adachi
- Takayuki OgawaTOTakayuki Ogawa
- Ri-Ichi MurakamiRMRi-Ichi Murakami
- Natsuo YasuiNYNatsuo Yasui
- 1 January 2002
- journal article
- Published by Japan Society of Physiological Anthropology in Journal of PHYSIOLOGICAL ANTHROPOLOGY and Applied Human Science
- Vol. 21 (5) , 235-238
Abstract
We investigated the effects of cyclooxigenase-2 (cox-2) on fracture healing. After closed non-displaced fractures were created at the middle of both femoral shafts in 12-week-old Wister rats, a cox-2 specific inhibitor, etodolac (20 mg/day; intra-peritoneal) was administered every day for three weeks (E group). Bone union and callus formation were evaluated by weekly radiographs. Three weeks after surgery, the mechanical strength of the fractured femur was evaluated by a three-point-bending test. These results were compared with those of a vehicle control group (V group). The fracture healing score on radiographs in the E group three weeks after the surgery was 3.3 +/- 0.9, and in the V group it was 5.8 +/- 1.5, indicating that fracture healing was significantly poorer in the E than the V group (p < 0.05). From the three point bending test, the ultimate strength and stiffness of etodolac-treated fractured femurs were shown to be significantly lower than those in vehicle control group (p < 0.05). Mechanically, femurs of etodolac treated rats were weaker than those of control rats. Thus, it was concluded that etodolac, a cox-2 specific inhibitor, inhibited fracture healing.Keywords
This publication has 9 references indexed in Scilit:
- Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's DiseaseNew England Journal of Medicine, 2001
- Impaired Intramembranous Bone Formation during Bone Repair in the Absence of Tumor Necrosis Factor-Alpha SignalingCells Tissues Organs, 2001
- COX-2 and colon cancerInflammation Research, 1998
- Effect of Nonsteroidal Antiinflammatory Drugs on Fracture HealingJournal of Orthopaedic Trauma, 1995
- The expression of cytokine activity by fracture callusJournal of Bone and Mineral Research, 1995
- Acidic fibroblast growth factor (aFGF) injection stimulates cartilage enlargement and inhibits cartilage gene expression in rat fracture healingJournal of Orthopaedic Research, 1990
- Increased mechanical strength of the vitamin D-replete rat femur by the treatment with a large dose of 24R,25(OH)2D3Bone, 1989
- Production of a standard closed fracture in laboratory animal boneJournal of Orthopaedic Research, 1984
- The Effect of Indomethacin Upon Experimental Fractures in the RatActa Orthopaedica, 1982